EUVIMEDAtrasti EUVIMED
Open access · CC BY 2.0

Ex vivo pretreatment of donor organ with siRNA nanoparticles attenuates cold ischemia-reperfusion injury in cardiac transplantation

Shun Yuan, Jianlin Che, Zhixiang Bo, Li Li, Yuanyang Chen, Xiaoping Xie, Ming Du, Lin Shen iD

Clinical Science · 2026-07-15 · 140 (7) · 1551-1573

DOI: 10.1042/cs20250653 ↗

At a glance

Journal article in Clinical Science, published online on 2026-07-03. Written by Shun Yuan and 7 co-authors. Institution: Department of Cardiothoracic Surgery, the Second Affiliated Hospital of Chongqing Medical University, 288# Tianwen Avenue, Chongqing City, People's R…. Major MEDLINE topics: Heart Transplantation, RNA, Small Interfering, Nanoparticles, Cold Ischemia. 49 references. The full text is freely available (open access, CC BY 2.0). Funded by: The Second Affiliated Hospital of Chongqing Medical University.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Heart transplantation is an optimal therapeutic regimen for terminal-stage cardiac failure. However, cold ischemia-reperfusion injury (CIRI) remains an unavoidable and outstanding challenge, which is a significant obstacle to early graft dysfunction and long-term survival. Blockage of complement, apoptosis, and inflammation by small interfering RNA is considered a strategy for attenuating CIRI and protecting cardiac function. However, their delivery to the donor organ is still a serious challenge due to the polyanionic nature and high molecular weight properties. Here, we have designed a novel functionalized gene delivery system of direct delivery and sustained release of siRNAs targeting complement C3 (C3), Caspase-3, and nuclear factor κB (NF-κB) to treat the donor organ prior to transplantation. The functionalized gene delivery system (siRNA-TNPs), composed of CaCO3/CaP/TAT embellished carboxymethyl chitosan (CaCO3/CaP/TCMC) and synthesized through the co-precipitation method, efficiently encapsulates siRNAs during self-assembly. The siRNA-TNPs safeguards siRNAs from biological degradation, facilitates intracellular siRNA transfection, promotes lysosomal escape, and enhances the delivery efficiency of siRNA to the donor hearts. Perfusion of donor hearts with siRNA-TNPs prior to transplantation attenuated C3, Caspase-3, and NF-κB genes expression of donor heart for at least 5 days after transplantation. Furthermore, silencing of C3, Caspase-3, and NF-κB genes expression alleviated cell apoptosis, myocardial damage, tissue inflammation, and rejection and improved cardiac function. These data suggest that the multiple-target siRNA-TNPs solution can extend the preservation time for donor grafts, attenuate IRI, and protect cardiac function in murine models of heart transplantation, which provides a principal of concept for potential clinical translation.

Subjects

MeSH terms (MEDLINE)

Heart TransplantationRNA, Small InterferingNanoparticlesCold IschemiaReperfusion InjuryMyocardial Reperfusion InjuryAnimalsCaspase 3NF-kappa BMaleChitosanComplement C3ApoptosisGene Transfer TechniquesRNAi TherapeuticsMice, Inbred C57BL

Author keywords

Carboxymethyl chitosan hybrid nanoparticlesCold I/R injuryGene deliveryHeart transplantationsiRNA

Substances

RNA, Small InterferingCaspase 3NF-kappa BChitosanComplement C3

Authors and institutions

  • Department of Cardiothoracic Surgery, the Second Affiliated Hospital of Chongqing Medical University, 288# Tianwen Avenue, Chongqing City, People's Republic of China.
  • Central Laboratory, the Second Affiliated Hospital of Chongqing Medical University, 288# Tianwen Avenue, Chongqing City, People's Republic of China.
  • Department of Cardiovascular Surgery, Wuhan University Renmin Hospital, 238# Jiefang Road, Wuhan 430000, Hubei Province, People's Republic of China.

ORCID profiles: Lin Shen

Funding

  • The Second Affiliated Hospital of Chongqing Medical University

Cite

APA

Yuan, S., Che, J., Bo, Z., Li, L., Chen, Y., Xie, X., Du, M., & Shen, L. (2026). Ex vivo pretreatment of donor organ with siRNA nanoparticles attenuates cold ischemia-reperfusion injury in cardiac transplantation. Clinical Science, 140(7), 1551-1573. https://doi.org/10.1042/cs20250653

Vancouver

Yuan S, Che J, Bo Z, Li L, Chen Y, Xie X, et al. Ex vivo pretreatment of donor organ with siRNA nanoparticles attenuates cold ischemia-reperfusion injury in cardiac transplantation. Clinical Science. 2026;140(7):1551-1573. doi:10.1042/cs20250653

BibTeX
@article{Yuan2026,
  author = {Yuan, Shun and Che, Jianlin and Bo, Zhixiang and Li, Li and Chen, Yuanyang and Xie, Xiaoping and Du, Ming and Shen, Lin},
  title = {Ex vivo pretreatment of donor organ with siRNA nanoparticles attenuates cold ischemia-reperfusion injury in cardiac transplantation},
  journal = {Clinical Science},
  year = {2026},
  volume = {140},
  number = {7},
  pages = {1551--1573},
  doi = {10.1042/cs20250653}
}
Start for free →